Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04679012
Title Polatuzumab Vedotin in Combination With Chemotherapy in Subjects With Richter's Transformation
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Weill Medical College of Cornell University
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Mount Sinai- Icahn School of Medicine RECRUITING New York New York 10029 United States Details
Columbia University Medical Center RECRUITING New York New York 10032 United States Details
Weill Cornell Medicine RECRUITING New York New York 10065 United States Details
Ohio state University RECRUITING Columbus Ohio 43210 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field